[go: up one dir, main page]

WO2013038120A3 - Dispositif de stockage et de distribution de liquide - Google Patents

Dispositif de stockage et de distribution de liquide Download PDF

Info

Publication number
WO2013038120A3
WO2013038120A3 PCT/FR2012/052080 FR2012052080W WO2013038120A3 WO 2013038120 A3 WO2013038120 A3 WO 2013038120A3 FR 2012052080 W FR2012052080 W FR 2012052080W WO 2013038120 A3 WO2013038120 A3 WO 2013038120A3
Authority
WO
WIPO (PCT)
Prior art keywords
storing
liquid
dispensing liquid
prostaglandin
coating
Prior art date
Application number
PCT/FR2012/052080
Other languages
English (en)
Other versions
WO2013038120A2 (fr
Inventor
Thierry Rimlinger
Pascal Dugand
Nolwenn Stephan
Original Assignee
Rexam Healthcare La Verpilliere
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rexam Healthcare La Verpilliere filed Critical Rexam Healthcare La Verpilliere
Publication of WO2013038120A2 publication Critical patent/WO2013038120A2/fr
Publication of WO2013038120A3 publication Critical patent/WO2013038120A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D105/00—Coating compositions based on polysaccharides or on their derivatives, not provided for in groups C09D101/00 or C09D103/00
    • C09D105/04—Alginic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D101/00—Coating compositions based on cellulose, modified cellulose, or cellulose derivatives
    • C09D101/08—Cellulose derivatives
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D101/00—Coating compositions based on cellulose, modified cellulose, or cellulose derivatives
    • C09D101/08—Cellulose derivatives
    • C09D101/16—Esters of inorganic acids
    • C09D101/18—Cellulose nitrate
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D101/00—Coating compositions based on cellulose, modified cellulose, or cellulose derivatives
    • C09D101/08—Cellulose derivatives
    • C09D101/26—Cellulose ethers
    • C09D101/28—Alkyl ethers
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D101/00—Coating compositions based on cellulose, modified cellulose, or cellulose derivatives
    • C09D101/08—Cellulose derivatives
    • C09D101/26—Cellulose ethers
    • C09D101/28—Alkyl ethers
    • C09D101/284—Alkyl ethers with hydroxylated hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D183/00—Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon, with or without sulfur, nitrogen, oxygen, or carbon only; Coating compositions based on derivatives of such polymers
    • C09D183/10—Block or graft copolymers containing polysiloxane sequences
    • C09D183/12—Block or graft copolymers containing polysiloxane sequences containing polyether sequences
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D5/00—Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced; Filling pastes
    • C09D5/14—Paints containing biocides, e.g. fungicides, insecticides or pesticides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/42—Block-or graft-polymers containing polysiloxane sequences
    • C08G77/46—Block-or graft-polymers containing polysiloxane sequences containing polyether sequences

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne un dispositif de stockage et de distribution de liquide pharmaceutique tel que du liquide ophtalmique. Plus particulièrement, le liquide ophtalmique comprend, en tant que principe actif, au moins une prostaglandine, au moins un analogue d'une prostaglandine ou au moins une protéine, notamment pour le traitement du glaucome. Le dispositif selon l'invention comprend, sur au moins une partie d'une surface interne du dispositif, un revêtement réduisant la sorption du liquide sur la surface revêtue, ce revêtement étant hydrophile.
PCT/FR2012/052080 2011-09-16 2012-09-17 Dispositif de stockage et de distribution de liquide WO2013038120A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1158280 2011-09-16
FR1158280 2011-09-16

Publications (2)

Publication Number Publication Date
WO2013038120A2 WO2013038120A2 (fr) 2013-03-21
WO2013038120A3 true WO2013038120A3 (fr) 2014-10-30

Family

ID=47883850

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2012/052080 WO2013038120A2 (fr) 2011-09-16 2012-09-17 Dispositif de stockage et de distribution de liquide

Country Status (1)

Country Link
WO (1) WO2013038120A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3820445A1 (fr) 2018-07-09 2021-05-19 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Dispositif de distribution ophtalmique

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461334B1 (en) * 1998-03-06 2002-10-08 Novo Nordisk A/S Medical article with coated surfaces exhibiting low friction and protein adsorption
US20040029834A1 (en) * 2000-11-02 2004-02-12 Thomas Schiestel Object having a microbicide coating, method for the production thereof and use of the same
US20070187280A1 (en) * 2006-01-11 2007-08-16 Daniel Haines Method of preparing a macromolecule deterrent surface on a pharmaceutical package

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461334B1 (en) * 1998-03-06 2002-10-08 Novo Nordisk A/S Medical article with coated surfaces exhibiting low friction and protein adsorption
US20040029834A1 (en) * 2000-11-02 2004-02-12 Thomas Schiestel Object having a microbicide coating, method for the production thereof and use of the same
US20070187280A1 (en) * 2006-01-11 2007-08-16 Daniel Haines Method of preparing a macromolecule deterrent surface on a pharmaceutical package

Also Published As

Publication number Publication date
WO2013038120A2 (fr) 2013-03-21

Similar Documents

Publication Publication Date Title
HK1198631A1 (en) Prevention and treatment of ocular conditions
EP3270992A4 (fr) Vaporisateur pour vaporiser un ingrédient actif
WO2012012772A3 (fr) Hydrogels à élution de médicaments destinés à être administrés par cathéter
WO2015106269A8 (fr) Formulations d'insuline à action rapide et systèmes d'administration pharmaceutique
WO2014085307A3 (fr) Dépôt par rotation combinatoire
EP3840733A4 (fr) Oligonucléotides antisens ciblant scn2a pour le traitement d'encéphalopathies scn1a
WO2014096854A3 (fr) Dispositifs ophtalmiques pour administrer des agents à effet bénéfique
EP3706729A4 (fr) Composés fusogènes pour l'administration de molécules biologiquement actives
EP4081169A4 (fr) Dispositifs médicaux pour distribution de fluide
EP3266317A4 (fr) Composition pour prévenir, améliorer ou traiter des troubles neurologiques, contenant un peptide d'osmotine comme principe actif
EP3863703A4 (fr) Inhalateur de brume à ultrasons
WO2012163827A3 (fr) Préparation ophtalmique contenant un analogue de pgf2alpha
HK1244431A1 (zh) 多泡沫体及其眼睑施用
EP4037740A4 (fr) Nébuliseur acoustique pour la livraison d'agents actifs
MX2011009100A (es) Anticuerpo humanizado pcrv que tiene actividad anti-pseudomonal.
EP4031218A4 (fr) Nébulisateur à ultrasons
WO2007034013A3 (fr) Dispositif pneumatique pour la production d'un aerosol sterilise par vaporisation partielle
EP3668991A4 (fr) Nanosupports pour l'administration de principes actifs
WO2012100109A3 (fr) Goutte ophtalmique thérapeutique comprenant de la doxycycline et un agent stabilisant
EP3978144A4 (fr) Dispositif de dépôt de gouttelette
WO2013138338A3 (fr) Méthodes de traitement de lésions tissulaires, associées à l'ischémie, faisant appel à l'apolipoprotéine d
WO2013038120A3 (fr) Dispositif de stockage et de distribution de liquide
WO2007107605A3 (fr) Procede destine au traitement d'une surface hydrophobe par une phase aqueuse
WO2013038119A3 (fr) Dispositif de stockage et de distribution de liquide pharmaceutique
WO2012142476A3 (fr) Méthodes et compositions utilisées pour le traitement du syndrome de marfan et des troubles associés

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12831306

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12831306

Country of ref document: EP

Kind code of ref document: A2